Sandsynligheden for at opnå et vedvarende virologisk respons med 48 eller 72 ugers behandling, hvis viral suppression var opnået ved uge 12, var henholdsvis 35% (20/ 57) og 57% (57/ 100).
The probabilities of achieving a sustained virological response with 48 or 72 weeks of treatment if viral suppression was achieved at week 12 were 35% (20 of 57) and 57% (57 of 100), respectively.